. Correction to "A Double-Blind, Placebo-Controlled Trial of Rosiglitazone for Clozapine-Induced Glucose Metabolism Impairment in Patients with Schizophrenia". Acta Psychiatr Scand 2025 Nov 3. doi: 10.1111/acps.70044.
PMID: 41184203